Next step was to investigate where each miRNA interferes in often-changed pathways in CRC (e.g., WNT, TGFβ, RAS, PI3K-AKT, TP53, MAPK, and MSI signaling pathways)28,30–34. This evidence concerns the gene TP53 and colorectal carcinoma.